New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
06:36 EDTNBIXNeurocrine Biosciences initiated with a Buy at Lazard Capital
Target $13.
News For NBIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 20, 2015
08:02 EDTNBIXNeurocrine announces oral presentation of NBI-77860 trial data
Neurocrine Biosciences announced that the steering committee of ENDO 2015 has selected the abstract of their recently completed clinical study of NBI-77860 in classic congenital adrenal hyperplasia for an oral presentation on the initial day of the Endocrine Society's 97th Annual Meeting. The ENDO 2015 meeting will be held in San Diego from March 5-8.
07:52 EDTNBIXNeurocrine price target raised to $39 from $32 at Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use